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The objective of this study was to evaluate scaffold culture conditions using 
computational fluid dynamics (CFD) and experimentation for supporting three-
dimensional (3D) hepatocyte cultures.  I used a CFD software to simulate 3D static 
bioreactors and two different designs of axial-flow bioreactors to assess the effect of 
scaffold thickness (0.25mm to 2mm), location within the culture (zero to 1mm), and 
scaffold porosity (0.25 and 0.85) and compare with experimental results obtained using 
HepG-2 cells.  A 14mm diameter chitosan-gelatin (CG) scaffold (0.85 porosity) prepared 
by freeze drying of various thicknesses to be placed in a six-well plate was simulated.  
Simulations were performed at constant cell density and exponential growth in each 
scaffold thickness.  Axial-flow bioreactors were constructed in-house according to the 
simulated dimensions.  Changes in the concentration of three components (oxygen, 
estrogen and urea) were evaluated using rate constants from literature.  Static bioreactors 
were simulated for 48 h (typical media culture duration) and axial-flow bioreactors were 
simulated at steady state flow rates ranging from 0.1mL/min to 10 mL/min.  
Concentrations of all three molecules were affected by placement of the scaffold at 0mm 
as molecules could not diffuse into the scaffold through the bottom.  These results 
showed that scaffolds thicker than 0.5mm scaffolds in static bioreactors were not capable 
of supporting three-dimensional liver tissue cultures due to oxygen diffusion limitations.  
Only oxygen concentration profiles were affected by a further increase in elevation as the 
static bioreactor was open to the atmosphere and oxygen could diffuse into the media 
from the air.  Simulation results were validated by measuring oxygen consumption and 
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Approximately 2 billion prescriptions are filled each year in the United States; however, few fully 
understand the amount of time, money, resources, and man power necessary to develop a new 
medication.  An assortment of scientists, chemists, physiologists, pharmacologists, molecular 
biologists, toxicologists, and statisticians must work together to gather data and give input for the 
development of a single drug.  A company can plan to spend an average of 12 years and $350 
million on the process of evolving a medication from a project in a research laboratory to a 
product at the pharmacy counter [7].  The high price tag is a result of company investment in 
drugs that fail.  Despite the time, money, and effort input by numerous professionals, 
approximately 95% of drugs studied in humans fail to be effective and safe [13].  Efforts are 
constantly being made to try to improve the efficiency of the drug development process.  
The liver is the metabolic hub of the body, where substances (i.e. drugs) are broken down to form 
by-products.  In some cases, the body is incapable of excreting a sufficient amount of toxic by-
products, and the liver becomes damaged.  Drug-induced liver injury, termed hepatotoxicity, is 
the most common reason for the after-market withdrawal of a drug, despite effectiveness in 




numerous, less complex hepatocyte culture systems have been investigated [2, 10, 34].  Issues 
with incubation periods, diffusion limitations, and nutrient distribution have been reported in 
many systems, as hepatocytes have a significantly higher level of function relative to other cell 
types.  Oxygen deficiency has most commonly been reported as a limiting factor in the 
investigation of highly metabolically active hepatocyte cultures.  Being able to visualize and 
better understand nutrient distribution in these systems would allow for system optimization and 
more accurate results when nutrient/toxin distribution is uniform relative to all cells. 
Computational fluid dynamics (CFD) is a powerful modeling tool used in many areas of chemical 
engineering and biomedical engineering to simulate flows of gases and liquids, heat and mass 
transfer, moving bodies, multiphase physics, and chemical reactions.  Simulation of cell culture 
systems using CFD allows for system optimization via parameter variation.  These simulations 
would provide a better understanding of nutrient/toxin distribution throughout systems, allowing 
for more accurate signaling results for application in toxicity testing.  
Based on this concept, this study focused on modeling the hepatocyte cultures in static cultures 
and bioreactors, and validating these with experimental results.  I utilized three different 
components in my analysis: i) consumption of oxygen which is necessary for the survival and 
function of hepatocytes; ii) production of metabolic product, urea, which is unique to the liver, 
and iii) estrogen, a hormone known to play a significant role in metabolic function of the liver.  
Initial concentrations were either based on solubility or physiological level.  I used commercially 
available CFD software (Comsol Multiphysics 4.3b) to assess the effect of a 14mm diameter 
scaffold with various thicknesses, elevations, porosities, and constant vs. increasing cell density.  
Michaelis–Menten rate constants from literature were used for oxygen and estrogen.  For urea 
production, a zero order reaction was used.   




i)  To understand the limitations of the static bioreactor via CFD Simulation. 
A 3D static culture of various scaffold thicknesses to be placed in a six-well plate was simulated.  
In static cultures, changes in the concentration of oxygen, estrogen and urea were evaluated over 
a 48 h time period (typical media culture duration).  Fluid properties were that of water, and 
effective diffusivities were based on the Mackie-Meares relationship.  Overall concentrations in 
the static culture were determined through multiple point analysis of Fick’s Law and rate laws at 
nodes throughout the three dimensional structure.  Model concentration distributions were tracked 
as scaffold thickness, porosity, cell count, and elevation were varied.  Time-dependent 
concentration profiles were analyzed for 1mm, 0.75mm, 0.5mm, and 0.25mm thick scaffolds of 
0.85 and 0.25 porosities for a constant and increasing cell count in order to determine limitations.  
These results showed that scaffolds 0.5mm and thicker were not capable of supporting three-
dimensional liver tissue cultures due to oxygen diffusion limitations.  I questioned whether it 
would be beneficial to change the location of the scaffold within the growth medium.  Increasing 
the elevation was shown to reduce the effective thickness for oxygen transport while altering the 
concentration of nutrients dissolved in the medium.  Scaffold elevations of 0mm, 0.5mm, and 
1mm with respect to the bottom of the bioreactor were examined.  Concentrations of all three 
molecules were affected by placement of the scaffold at 0mm as molecules could not diffuse into 
the scaffold through the bottom.  Only oxygen concentration profiles were affected by a further 
increase in elevation as the static bioreactor was open to the atmosphere allowing oxygen to 
diffuse into the media from air.   
ii)  To develop an axial-flow bioreactor via CFD Simulation. 
Due to scaffold thickness limitations in the static bioreactor, an axial-flow bioreactor of identical 
dimensions was simulated (referred as Case 1).  A truncated version (referred as Case 2) of the 
axial-flow bioreactor to exactly fit the scaffold diameter was also investigated to optimize 




1mm and 2mm thicknesses were investigated at 0.25 and 0.85 porosities.  The shape of the 
bioreactor was initially optimized for uniform nutrient distribution.  Then concentration profiles 
were determined at steady-state for each molecule, using similar rate kinetic parameters in a 
convective-diffusion equation.  Scaffold elevation was set at 0.5mm from the bottom of the 
bioreactor.  Toxicity due to build-up of urea was not a concern in the axial-flow bioreactors.  
Fluid flow rate was varied to test the effect on nutrient sufficiency and shear stresses experienced 
by cells.  In the truncated version, uniform oxygen distributions were observed even at flow rates 
as low as 0.1 mL/min.  These analyses led to the conclusion that Case 2 bioreactors should be 
constructed for experimental validation of the model.  
iii):  To validate the axial-flow bioreactor simulation with experimental results. 
Axial-flow bioreactors were constructed in-house according to the simulated dimensions.  
Chitosan-gelatin scaffolds of 0.85 porosity were prepared by freeze drying technique.  A 
residence time distribution (RTD) analysis was performed to determine nutrient distribution 
including the bioreactor and scaffold.  Tracer was introduced as a step input at a volumetric flow 
rate of 0.1mL/min.  Obtained mean residence time (tm) was compared with the theoretical space 
time calculated from the volumetric flow rate and the volume of the bioreactor.  These 
calculations showed distribution of nutrients in the entire region with less than 5% dead space.  
These regions are similar to those observed in simulation results.  Then, experiments were 
performed using a hepatocarcinoma cell line (HepG-2 cells from ATCC) at the cell density used 
in all simulations.  Oxygen consumption was measured using an in-line flow through electrode at 
the bioreactor outlet.  Urea concentration was measured from the samples collected using a 
spectrophotometric assay.  These results showed agreement with the simulation results.   
These results show the possibility of using axial-flow bioreactors for use in testing hepatotoxicity.  
Using these conditions, one could develop multiple wells and bioreactors that could be used in 











2.1.  THE DRUG DEVELOPMENT PROCESS 
New medicines and treatments are developed through a series of controlled trials in which the 
efficacy and toxicity of a drug are analyzed.  A drug must pass through several phases of the 
process before even being considered for Federal Drug Administration approval (Figure 2.1).  An 
enormous amount of research is performed before laboratory tests begin.  During the preclinical 
phase, laboratory and animal tests are performed to assess drug safety and biological activity.  In 
phase 1 of clinical trials, tests are performed on healthy, human volunteers in order to assess drug 
safety and determine dosage.  Phase 2 of clinical trials evaluates drug efficacy and side effects in 
patient volunteers.  Finally, in phase 3 of clinical trials, tests are performed to verify drug efficacy 





Table 2.1:  Phases of the drug approval process.  
www.medscape.com 
 
2.2.  DRUG DEVELOPMENT AND THE LIVER 
The liver is a multifunctional organ involved in the metabolism, detoxification, and excretion of 
many substances essential for homeostasis.  Thus, the liver is known as the metabolic hub of the 
body, the location where nutrients and toxins alike travel, are broken down, and are either 
circulated to the rest of the body or excreted.  Liver tissue cultures are used in the preclinical 
stage of drug development due to the liver’s vital role in the detoxification of the body.  More 
specifically hepatocyte cultures are used, as these cells comprise 80% of the liver.  Many in vitro 
culture techniques using HepG2 cells, a hepatocyte derived cell line from the liver, have been 
explored [2, 10, 34].  Although primary hepatocytes serve as an excellent in vitro model for drug 
metabolism in the body, difficulties are encountered in finding supplies of disease-free cells (in 
many cases cirrhotic), that are steadily available.  Thus, HepG2 cells, which are considerably 
easier to handle and cheaper have been used extensively in the evaluation of drug toxicity for a 




2.4.  CURRENT HEPATOCYTE CULTURING SYSTEMS 
Numerous in vitro, hepatic cell culturing systems, such as cell suspension, co-culture systems, 
aggregate systems, and bioreactors, have been investigated.   
Two-dimensional cell culturing techniques have had success in maintaining cell proliferation.  
However, cell growth is restricted to a flat, tissue-culture treated surface which reduces the 
number of cells that could be cultured in a given volume of growth medium.  Also, 2D cultures 
are typically mono-cultures, consisting of only one cell type, and lack extracellular matrix or 
interstitial fluid.  Drugs to be tested in two-dimensional systems are exposed to only part of the 
cell surface, as the other side is exposed to the tissue culture surface material.   
 
Figure 2.1:  Structural comparison of 2D and 3D cell culture. 
 
Though these culturing systems are easy to set up and maintain, while still providing good cell 
viability; two-dimensional cell cultures are poor approximations of tissue in vivo.  Two-
dimensional cell cultures lack necessary architectural structure and face significant transport 
limitations, causing major limitations for the application of such culturing systems in drug 




Cell suspension systems on the other hand, are not restricted to a flat surface, nor must they be 
maintained in culture flasks that are tissue-culture treated. While this system allows for an 
increase in cell count and a non-tissue-culture treated environment, many drawbacks still exist.  
The anchor-dependent nature of the majority of vertebrate cells requires a specifically treated 
surface to promote cell adhesion and spreading.  Another issue encountered in cells suspension 
culturing systems is that as the culture volume to surface area ratio is increased beyond which 
adequate gas exchange is hindered (usually 0.2–0.5 mL/cm
2
), the medium requires agitation to 
adequately distribute nutrients throughout the system.  Agitation can also be a concern in systems, 
as convection in the system can cause shear stress issues that could result in cell death [11].  
Three-dimensional (3D) cell culture systems are preferred to two-dimensional culture systems 
because 3D cultures require less area to seed more cells [34].  With the introduction of 3D culture 
techniques as early as 1912 [4], the most simple one being the aggregate or spheroid culture 
(Figure 2.2), scientists have noticed that organotypic cell cultures are more readily developed in 
higher density cultures.   
 
Figure 2.2:  Hepatocyte Spheroids (Tissue Engineering in  
Regenerative Medicine; Bao et al. Chapter 17). 
 
A higher cell count improves sensitivity in toxicity measurements.  However, aggregate systems 
or spheroids have issues with uniform distribution of nutrients.  As distance from the surface of 




Cells located closer to the center of the aggregate are deprived of the nutrient level necessary to 
survive.   
With recent advances in tissue engineering and development of biodegradable porous structures, 
three-dimensional cell cultures have found increased popularity for the culturing of high density 
hepatocyte cultures.  Porous structures from various sources have been developed to culture 
hepatocytes in 3D models, including Matrigel® obtained from a mouse sarcoma [28].  However, 
in static culture systems, diffusion is the primary driving force for nutrient transport throughout 
the porous structure, dictated by Fick’s first law.  Many static bioreactor investigations have 
reported issues with incubation periods due to reliance on diffusion alone as a means of nutrient 
distribution [10].  The frequency with which media must be changed to maintain adequate 
nutrient supply can become problematic.   
2.3.  HEAPTOTOXICITY TESTING 
The creation of a new medicine or treatment requires the development of a drug that effectively 
treats injury or disease.  However, effectiveness is not the only required quality in a new drug.  It 
is vital that new drugs and treatments be both effective and safe.  Hepatotoxicity testing is 
performed to analyze the toxicity and safety level of a drug.  Hepatotoxicity testing involves the 
evaluation of changes in biomarkers.  These changes include morphological changes, alteration of 
protein expression, mitochondrial respiration inhibition, and many more, depending on the 
biomarker of choice [14].  The presence of these markers at or above specific levels in 
hepatotoxicity analysis indicates toxic liver injury.  Over 900 drugs, toxins, and herbs have been 
reported to cause liver injury.   The most common cause for after-marketing withdrawal of a drug 
is drug-induced liver injury [20].  This indicates serious limitations in preclinical testing systems 
as well as large gaps in knowledge of drug-specific metabolism [1].   Understanding metabolism 




capable of maintaining hepatocyte vitality while providing accurate readings of toxic signals from 
cells. 
2.5.  THE IMPORTANCE OF OXGEN CONSUMPTION ANALYSIS 
As previously discussed, hepatocyte cultures are used in drug development analysis.  Because 
hepatocytes are known for a higher level of metabolic rate relative to other cell types, one has to 
understand the distribution of various components in in vitro models [17, 23]. This knowledge is 
vital to the drug development process, as the uniformity of distribution of nutrients and toxins to 
cells affects the accuracy of signal results.  Inadequate nutrient distribution leads to decreased cell 
viability, lowered growth rates and poor functionality and thereby leads to poor reliability of data 
[3, 21]. 
2.6.  ESTROGEN AND THE LIVER 
The ovarian sex hormone 17β-estradiol (MW=232.4 g/mol), commonly referred to as estrogen, is 
involved in metabolism apart from reproductive functions.  The liver is a site for biosynthesis of 
estrogens, and the main site for further biotransformation.  Once the estrogens are synthesized by 
aromatase in peripheral tissues including the liver, they are released to the circulation system.  





Figure 2.3:  Estrogen metabolism in the liver.   
Copyright:  by PharmGKB.  With permission from PharmGKB and Stanford University 
(https://www.pharmgkb.org/pathway/PA145011118) 
 
Understanding how uptake of different molecules and diffusivities change is important to 
determine the usage of 3D cultures.  I wanted to investigate the effect of increased molecule size 
on concentration distribution.  As estrogen is a considerably large molecule (relative to urea and 




2.7.  UREA AND THE LIVER 
The metabolic waste from nitrogenous by-products of amino acid break down in the liver are 
converted into urea, a polar molecule (MW= 60 g/mol) which readily dissolves in water, and in 
disposed of via the renal system.   
 
Figure 2.4:  Basic process of urea production from amino acids.   
The main chemical reactions for the synthesis of urea from ammonia (NH3) according to the path 
shown in Figure 2.3 are as follows: 
2NH3 + CO2   H2N-COONH4 
H2N-COONH4   (NH2)2CO + H2O 
As amino acids are present in media supplied to cells to provide nutrients necessary for survival, 
urea is expected to be produced.  Very high concentrations of urea are toxic to cells and could be 
necrotic.  In the clinical setting, the normal level of urea in plasma is around 30mg/100mL and 
increase of this value to 50mg/100mL is considered high and a possible indication of improper 
liver functionality [37].  Understanding urea production and distribution in in vitro hepatic cell 
cultures is vital to ensuring that urea toxicity does not occur and in turn affect cell vitality or the 
accuracy of signaling results. 
2.8.  COMPUTATIONAL FLUID DYNAMICS AND MATHEMATICAL MODELING 
The use of CFD programming to visualize and better understand nutrient distribution in 
hepatocyte culturing systems is vital to creating an optimized system.  One of the greatest features 
of simulation is that parameter changes can easily be made.  Some parameter changes to a 




multiple models, which can become expensive.  CFD coupled with reaction kinetics can provide a 
better understanding of nutrient consumption and toxin production in cell culture systems.  This 
improved knowledge base allows nutrient deficiency and toxicity issues to be addressed more 
efficiently, which can then be applied to experimental analysis.   
Reaction kinetics differ according to the molecule being consumed or produced.  Michaelis-
Menten kinetic values can be readily obtained from literature for numerous molecules.  These 
values (specific values discussed in chapter 3) were discovered in literature for both estrogen and 
oxygen.  This is why the Michaelis-Menten equation was used to characterize the consumption 
rate of these two molecules.  As Michaelis-Menten constants were not available for determining 
the rate of urea production, the production rate of urea was determined to be based on a zero 
order equation based on literature (specific details discussed in chapter 3).  Cell density plays a 
big role in determining the rate at which a molecule is consumed or produced.  Growth rate 
characteristics have not been previously considered when looking at long term incubation of cells.  
Considering the doubling time of cells would significantly impact molecular 
consumption/production rates.   
Molecular transport must also be taken into consideration when simulating cell culture systems.  
Diffusion dominated transport of static cell culture systems is characterized by Fick’s law for 
reacting systems.  In a non-static system, like the flow-through bioreactor, molecular transport by 
convection is considered in addition to diffusional transport.  Fluid flow in such systems is 
characterized by the Navier-Stokes equation (shown in chapter 4) in non-porous regions, and by 
the Brinkman or Darcy equation (shown in chapter 4) in porous regions.  CFD programs combine 
the molecular transport and reaction kinetics equations, along with a number of defined initial 
conditions (i.e. concentration or velocity) to create a multitude of profiles, such as pressure 
gradients, velocity profiles, and concentration profiles.  These profiles provide a wealth of 




better understand better understanding of results, and can aide in determining accuracy of 
signaling results in toxicity testing.   
2.9.  BIOREACTORS  
A way to improve the nutrient distribution is by constant mixing or applying flow systems where 
nutrient distribution is facilitated by convection.  Bioreactors have been of particular interest due 
to the degree of control over system parameters.  Successful culturing in bioreactors has resulted 
in the development of numerous bioreactor types in a variety of shapes and sizes.  Although flow-
through bioreactors can provide more uniform nutrient concentration distributions, shear stress 
exerted on cells must be considered.  Hence, few different flow configurations have been 
explored.  For example, axial-flow reactors flow vertically in an upward direction through the 
cell-seeded region, while parallel-flow reactors flow horizontally through or above the cell-
seeded region. Figure 2.5 shows some examples of flow-through bioreactors that have been 
previously investigated.   
 
Figure 2.5:  Flow-through bioreactor examples. 
Optimization of bioreactor shape has been investigated, showing that rounded reactors contain 




demonstrated increased uniformity of nutrient distribution [29].  While many of the systems 
discussed have been constructed and used for experimental analysis, little research has been done 













Various approaches by others have been explored to colonize hepatocytes within porous 
scaffolds.  One method is the transformation of the tissue culture plastic technique, where 
hepatocytes are populated in a batch culture on flat plates.  Porous scaffolds containing 
hepatocytes are inserted into the tissue culture well and fed with the growth medium. Hepatocytes 
are supplied with nutrients by adding a certain amount of medium that is replenished frequently, 
typically at 48 hour intervals.  This method has been successfully used to regenerate very thin 
structures.  However, adapting the technique to a thicker structure is not well understood, 
particularly the limitations of these batch bioreactors in the distribution of nutrients and removal 
of metabolic products.  In this study, I evaluated the static culture for the capability to support a 
three-dimensional hepatic culture.  I examined nutrient and metabolic product concentration 
distributions throughout the cell-seeded scaffold.  CFD simulation (COMSOL 4.3b) was used to 
examine hepatocyte consumption of oxygen and estrogen, as well as urea production.  The 
scaffold thickness, porosity, constant versus increasing cell count, and elevation from the bottom 




distributions.  For each analysis the oxygen, estrogen, and urea concentration distributions and 
volume-average concentrations were evaluated.  These evaluations provided data for environment 
limitation analysis.   
3.2.  SIMULATION SETUP 
3.2.1.  Bioreactor Geometry 
A discoid shape, static bioreactor with a height of 2.34mm and a 16.5mm radius was simulated 
(Figure 3.1).  Dimensions were based on those of a six-well plate available commercially.  The 
scaffold region had a radius of 7mm and was placed concentrically to the bioreactor.   
 
Figure 3.1:  Static bioreactor dimensions.  
(picture from COMSOL 4.3a simulation)  




 was used in simulation.  For each scaffold height, scaffold volume was calculated (Table 
3.1) and the number of Hep-G2 cells (hepatocarcinoma cell line used in experiments) seeded 
inside of the scaffold was determined.  A detailed example of the input of static bioreactor 










Scaffold Thickness (mm) Scaffold Volume (mm
3
) Number of cells 
1 153.94 200,000 
0.75 115.45 150,000 
0.5 76.97 100,000 
0.25 38.5 50,000 
 
3.2.2.  Governing Equations and Boundary Conditions 
Some initial assumptions were made in determining boundary conditions and properties to be 
used.  These assumptions are as follows: 
 The media properties were equivalent to those of water at 37°C.   
 The exposed top surface was saturated with oxygen at any given time, supplying a 
constant concentration similar to experimental culture methodology.  
 The diffusion values remained constant and isotropic.   
 There was no flux at any exterior boundaries. 
Media’s initial oxygen concentration of 0.225 mol/m
3
 was calculated at 37°C using Henry’s Law.  
The initial estrogen concentration to be added to the media was calculated based on the 
physiological concentration of estrogen in the body.  Lastly, the initial nitrogen concentration in 
media was determined using the nitrogen content of proteins [31] and the summation of the 
specific volume of  amino acids, a byproduct of protein digestion, in the media used (Eagle’s 
Minimum Essential Medium, a product of ATCC).  Detailed calculations for oxygen, estrogen 
and urea can be found in Appendix A, Appendix B and Appendix C, respectively. 
The physics module, Transport of a Diluted Species, was chosen based on governing equations 
for mass transport.  Mass transport through the scaffold region was assumed to follow Fick’s Law 








       (3.1) 
where 
t
Ci  is the change in concentration of molecule i over time, D is the diffusivity constant 
for molecule i in water,  is the second order gradients along each of the major dimensions in 
the system, and ri is the rate of consumption or production depending on the molecule, i, being 
evaluated.  In the scaffold region the effective diffusivity constant was used in Fick’s Law.  




eff DD        (3.2) 
where Deff is the effective diffusivity, D∞ is the free diffusivity of the molecule in water, and p is 
the porosity of the scaffold.  Calculated effective diffusivity values are shown in Table 3.2.  
Detailed diffusivity calculations for oxygen, estrogen, and urea are in Appendices A, B, and C 
respectively. 






















Oxygen[32] 3.00E-09 1.64E-09 6.12E-11 32 
Urea [5] 9.25E-08 5.05E-08 1.03E-09 60 
Estrogen[33] 4.00E-10 2.19E-10 8.16E-12 232.4 
 










r         (3.3) 
where Vm is the maximum uptake rate of molecule i, Ci is the concentration of the molecule at any 
time, and Km is the Michaelis-Menten constant for molecule i.  The Michaelis-Menten kinetic 
parameters used in this study for estrogen [8] and oxygen[6] are shown in Table 3.3.   
To account for cell growth, it was assumed that the doubling time for cells was 24 h.  The 
following differential equation was used to determine the change in the number of cells, ∂N, in 




        (3.4) 
where µ represents the specific growth rate constant and N0 represents the initial number of cells 
seeded in the scaffold.  An analytic function was input to simulation to vary the kinetic constant, 
Vm, over time.  Details of these calculations for oxygen and estrogen are in Appendix A and B, 
respectively.   
An zero order rate law was assumed for determining the rate of urea production (rUrea), 
krUrea         (3.5) 
where k is the rate constant.  The urea rate constant is based on the number of cells and thus 
increases as the number of cells increase.  The urea rate constants for each scaffold thickness can 






Table 3.3:  Rate law kinetics for oxygen, estrogen, and urea. 
Rate Law Kinetics 
 
Oxygen Estrogen Urea 
Km (mol/m
3







*s) 4.42E-5 9.53E-09 2.00 16.8 
   1.00 8.41 
   0.75 6.31 
   0.50 4.21 
   0.25 2.10 
 
Calculations for urea rate constants can be seen in Appendix C.  Detailed procedures for the input 
of boundary conditions and equations are provided in Appendix D. 
3.2.3.  Meshing 
Meshing of simulations was done using a free tetrahedral mesh for all geometry with a maximum 
element size of 0.5mm and a minimum element size of 0.2mm.  The number of nodes used for 
this simulation was 260,731.  A grid test was performed decreasing the maximum element size to 
0.4mm and increasing the number of nodes to 514,021.  The percent difference in the volume 
average concentration was 0.016%, which indicated that the mesh quality had been refined 
enough so as to not affect results. 
3.2.4.  Evaluation 
All simulations were performed for a 48 h duration, mimicking that of experimental conditions.  
Concentration profiles were created by simultaneously solving Equation (1) at mesh nodes 
throughout the three-dimensional static bioreactor.  The volume-average concentration was 




evaluation.  The procedure for obtaining concentration profiles for desired molecules and volume 
average concentrations are described in Appendix D.  
3.3. RESULTS 
3.3.1.  Oxygen Consumption Characteristics 
Typically when cells are cultured, growth medium is changed every alternate day.  It is expected 
that cells are exposed to the lowest amount of nutrients at the end of 48 h.  Hence, nutrient 
distribution at 48 h was analyzed.  Results from the simulation for oxygen consumption were 
analyzed for various scaffold thicknesses.  As scaffold thickness increased (Figure 3.2) and thus 
cell count increased, so did oxygen consumption.   
3.3.2.  Influence of Porosity on Oxygen Transport   
Characteristics of the porous scaffold change during tissue regeneration, i.e., permeability of the 
matrix to nutrient distribution decreases due to decreased pore size.  In order to simulate this 
condition, the effect of change of porosity from 85% to 25% on oxygen distribution was 
investigated.  Decreased porosity decreased the value of effective diffusivity input to the 
simulation (Appendix A).  Oxygen distribution at 48 h was tested in scaffolds of different 
thicknesses and assuming a constant cell density of 1.29x10
12 
for the two different porosities 
discussed.  Decreased porosity (Figure 3.2) decreased the overall scaffold oxygen concentration 
for all four scaffold thicknesses.  Oxygen deficient areas were not present in any of the 85% 
porosity scaffold thicknesses analyzed.  However, oxygen deficiencies were seen in the 1mm and 
0.75mm thick scaffold simulations at 25% porosity.   These deficiencies existed despite the 
abundance of oxygen outside of the scaffold, indicating that the effective diffusivity limited 
oxygen transport into the scaffold region.  As effective diffusivity is directly related to porosity, it 
was determined that scaffold porosity was a limiting factor for the static bioreactor at lower 







Figure 3.2:  Effect of porosity on oxygen consumption at 48 h for 85% porosity (left) and 25% porosity (right). 





3.3.3.  Influence of Cell Density on Oxygen Concentration Distribution  
The initial investigation assumed a constant cell density over the 48 h time period.  In a static cell 
culture it is important to consider cell growth in addition to scaffold porosity changes in order to 
account for accompanying variability in the reaction rate over time.  When cell growth was 
incorporated into the simulation, increased cell density (Figure 3.3) decreased the oxygen 
concentration in the scaffold region for all scaffold thicknesses when compared with those 
profiles at a constant cell density.  Increased cell density decreased oxygen concentration 
distribution uniformity in all scaffold thicknesses and at both porosities discussed.  The oxygen 
concentration profiles at 25% porosity after 48 h showed areas of severe oxygen deficiency, 
concentration near zero, in the scaffold region of the 0.75mm and 1mm thick scaffold 
simulations.  Though less severe, even the 0.5mm thick scaffold showed oxygen deficiency in the 







Figure 3.3:  Oxygen consumption with increasing cell density at 48 h for 85% porosity (left) and 25% porosity (right). 





In order to better understand the consumption profile, change in concentration of oxygen as a 
function of time was plotted for tested thicknesses at the discussed porosities for both a constant 
cell density and an increasing cell density.  These results (Figure 3.4) showed maximum decline 
within the first half hour for all simulations.  As scaffold thickness increased, overall oxygen 
concentration for the bioreactor decreased.  Decreased porosity led to further oxygen 
concentration decrease for all scaffold thicknesses.  
At 85% porosity, the overall oxygen concentration increased through the second half hour for all 
scaffold thicknesses.  This is attributed to the initial increase in consumption which created a 
concentration gradient.  Oxygen diffusion from the top surface is promoted due to the newly 
developed concentration gradient.  Steady state was reached by the end of the first hour when a 
constant cell density at 85% porosity was assumed.  On the other hand, when increased cell 
density as a function of time was considered, the oxygen concentration decreased exponentially 
beginning at the end of the first hour.  An exponential increase in the rate of consumption while 
maintaining the same rate of oxygen diffusion into and through the system explains the 
exponential decay in the overall oxygen concentration of the bioreactor.   
At 25% porosity, only the 0.25mm and 0.5mm thick scaffolds showed any increase in overall 
oxygen concentration.  Simulation for all four scaffold thicknesses, where a constant cell density 
was assumed, reached steady state even at 25% porosity.  However, the time period necessary to 
reach steady state increased as scaffold thickness increased.  This trend was not seen in the 85% 
porosity simulations.   This difference is attributed to the significant difference in effective 
diffusivity of oxygen through the scaffold region at the two different porosities, as well as the rate 
of diffusion of oxygen into the system from the atmosphere.  The rates of oxygen diffusion into 
the scaffold region and into the system from the atmosphere are much smaller than the rate of 





Figure 3.4:  Oxygen concentration in the media over time plot. 
Plots to the right are a closer view of the plots to the left.  Circles correspond to constant cell number simulation.  Inverted triangles 




The 25% porosity volume average concentration was lower after 48 hours when compared to the 
volume average concentration of the same scaffold thickness at 85% porosity.  The difference in 
volume average concentration at the two different porosities became more pronounced as scaffold 
thickness increased.   
3.3.4  Influence of Elevation on Oxygen Consumption 
Increased thickness and cell density, along with a decreased scaffold porosity showed significant 
deficiency of oxygen, particularly near the bottom of the static bioreactor.  Since there was 
sufficient oxygen at other areas except scaffolds, I questioned what would happen if the elevation 
of the scaffold was altered.  For this purpose, the elevation of the 1mm thick, 25% porosity 
scaffold with an exponentially increasing cell density was increased from 0mm to 0.5mm and 
1mm, progressively.  Analysis of oxygen distribution at 48 h showed (Figure 3.5) similar 
distribution profiles for all elevations.   
 
Figure 3.5:  Elevation effect on oxygen consumption at 48h in 1 mm thick scaffolds at 25% 
porosity, with increasing cell density. 
To better understand the effect of elevation, average concentration in the media at 48 h was 




scaffold was placed at 0mm, directly on the bioreactor bottom, volume average concentration in 
the media was higher.  This could be due to the cells along the bottom of the scaffold receiving 
little to no oxygen, resulting in less consumption and increasing the volume average 
concentration in the media.  As the elevation of the scaffold increased, the volume average 
concentration in the media decreased.  This demonstrated that hepatocytes consumed more 
oxygen as the scaffold approached an oxygen source.  However, a large portion of the scaffolds 
were still deficient in oxygen. 
 
Figure 3.6:  Effect of scaffold elevation on oxygen concentration for 1mm thick scaffolds at 
25% porosity. 
*h = 0, 0.5, and 1 are simulations with increasing cell density over time. 
 
3.3.5.  Changes on Estrogen Distribution 
Understanding how uptake of molecules and diffusivities change with different molecules is 




(MW=232.4 g/mol), commonly referred as estrogen and its receptors, estrogen receptor-α and 
estrogen receptor-β, are involved in metabolism apart from reproductive functions [12].  Hence, I 
evaluated estrogen consumption in the simulation involving the four scaffold thicknesses 
previously discussed.   
3.3.6  Scaffold Thickness and Porosity Influence on Estrogen Consumption 
Similar to oxygen, the effects of scaffold thickness and porosity on estrogen concentration 
distribution were analyzed.  For this analysis, a constant cell density was assumed.  These results 
showed (Figure 3.7) that estrogen consumption increased with scaffold thickness, due to the 
increased cell number.  Like oxygen, decreased porosity from 85% to 25% had a direct effect on 
the estrogen concentration distribution.  Note that the maximum and minimum values of the 
estrogen concentration color scales are succinct. Overall, estrogen concentration was non-
uniformly distributed, yet no deficient regions were observed. 
3.3.7  Effect of Cell Density Change on Estrogen Concentration Distribution 
Similar to oxygen, the effect that increasing cell density over time, due to cell proliferation, 
would have on estrogen concentration distribution was examined.  The results showed (Figure 
3.8) that increased cell density increased estrogen consumption for both porosities and all scaffold 
thickness simulated.  This was attributed to the increased cell number.  Even the most diverse 
estrogen concentration profile, the 1mm thick, 25% porosity scaffold, with an increasing cell 
density, did not show estrogen deficient areas.  This analysis showed that estrogen concentration 









Figure 3.7:  Effect of porosity on estrogen consumption at 48 h for 85% porosity (left) and 25% porosity (right). 








Figure 3.8:  Estrogen concentration distribution with increasing cell density at 48 h for 85% porosity (left) and 25% porosity (right). 






Similar to oxygen, the change in the volume average concentration of estrogen was plotted for the 
tested duration of 48 h.  These results showed (Figure 3.9) sequential decrease in estrogen value 
with increase in scaffold thicknesses.  Also, this decrease appeared linear when a constant cell 
density was assumed, most likely attributed to the slow uptake by cells.  An exponential decrease 
in volume average estrogen concentration appeared when an increasing cell density was assumed.  
This was attributed to the exponential increase in the cell number over time.  The difference in 
concentration between the 25% and 85% porosity plots is unperceivable, further supporting the 
assumption that concentration differences observed in the estrogen consumption profiles are 












3.3.5.  Urea Production 
Metabolic waste from the nitrogenous products are converted into urea and disposed via the renal 
system.  Urea is a polar molecule (MW= 60 g/mol) and readily dissolves in water.  In order to 
understand the productivity of urea and distribution in the scaffold, simulations were performed 
using the same four scaffold thicknesses discussed previously.   
3.3.6.  Effect of Scaffold Thickness and Porosity on Urea Concentration Distribution 
Similar to previous analysis for oxygen and estrogen, the influence of scaffold thickness and 
scaffold porosity were investigated for the production of urea, first assuming a constant cell 
density, and again assuming that cell density increased with time.  An increase in urea was 
observed (Figure 3.10) with an increase in scaffold thickness and cell number.  Both scaffold 
region and medium appeared to be of the same concentration at the end of 48-h.  This could be 
explained by the fact the urea production is limited by the diffusion of nitrogen into the scaffold 
where the reactions takes place.  Urea diffusion constants both inside and outside of the scaffold 
are larger than those of nitrogen.  This results in uniform distribution of urea throughout the 
bioreactor.  A decrease in porosity lowered the effective diffusivity values for both nitrogen and 









Figure 3.10:  Scaffold thickness effect on urea production for 85% porosity (left) and 25% porosity (right). 





3.3.7.  Influence of Cell Density on Urea Production 
Analysis of the influence of cell density on urea concentration distribution was performed, similar 
to that for oxygen and estrogen.  The urea concentration profiles (Figure 3.11) showed that an 
increasing cell density over time increased urea concentration for all scaffold thicknesses.  This 
was attributed to the increased cell number.  Also, as scaffold thickness increased, the difference 
in concentration between the constant cell count and increasing cell count simulations became 
more apparent.  Even when an increasing cell density was assumed, porosity had no effect on 
urea concentration profiles.   
 
Figure 3.11:  Effect of increasing cell density on urea concentration distribution for 85% 
porosity at 48 h. 
Shown are the cross-section views of the entire static bioreactor. 
The volume average concentration over time was plotted for all simulations.  The plots (Figure 
3.12) showed that the urea concentration in all four scaffolds increased constantly over time, 
when a constant cell density was assumed.  In the case of increasing cell density, an exponential 
increase in urea concentration over time was observed.  This was attributed to the exponential 





Figure 3.12:  Urea concentration in the media over time plot at 25% porosity. 
Very high concentrations of urea are toxic to the body and could be necrotic.  In the clinical 
setting, the normal level of urea in plasma is around 30mg/100mL and increase of this value to 
50mg/100mL is considered high and a possible indication of improper liver functionality.  The 
highest value, 240µmol/m
3
,was observed in the static bioreactor with 1mm thick scaffold when 
an increasing cell density over time was assumed, which corresponds to 1.44mg/100mL.  This 
would indicate that urea concentration would not be near the toxic condition at the end of 48-h.  
3.4  SUMMARY 
In summary, the effect of scaffold thickness, porosity, cell density, and elevation on oxygen, 
estrogen, and urea concentrations in a static cell culture environment were investigated via 
simulation.  Concentration profiles revealed that all varied parameters discussed had a direct 
effect on the uniformity of oxygen and estrogen concentration distributions.  As scaffold 
thickness increased, oxygen deficiency and urea toxicity issues increased.  Simulation showed 




cells along the bottom of the scaffold.  Decreased porosity coupled with an increasing cell density 
over time, led to oxygen deficiency issues in all scaffold thicknesses.  It was concluded that the 
static bioreactor was not capable of supporting three-dimensional hepatic cell cultures for the 














Mass transfer in the static bioreactor was diffusion limited, causing non-uniform oxygen 
distributions and oxygen deficiency issues.  The objective of this study was to test an axial-flow 
bioreactor capable of supporting three-dimensional hepatocyte cultures of scaffolds at least 1mm 
thick, similar to that of the static bioreactor.  Nutrient and metabolic product concentration 
distributions were examined throughout the scaffold region, similar to the static bioreactor.  
Computational fluid dynamics simulations were utilized to examine oxygen consumption and 
urea production.  Scaffold thickness and flow rate were varied in order to determine their effect 
on concentration levels and distributions.  Oxygen and urea concentrations, shear stress, and 
velocity profiles as well as pressure drop across the bioreactor were evaluated for each analysis.  





4.2 SIMULATION SETUP 
4.2.1. Bioreactor Geometry 
Case1.  Based on converting the static reactor into a flow system, similar proportions of 
bioreactor size and scaffold size were selected.  Since axial-flow configuration showed less 
deformation of the scaffold due to fluid flow, that configuration was selected [24].  The regions 
and geometry of the axial-flow bioreactor are shown in Figure 4.1.  Scaffold elevation was set 
0.5mm from the top of the inlet cylinder.  The hold-up region height was 0.84mm to match the 
2.34mm height of the static bioreactor.  The frustum semi-angle used was obtained from Bhaskar, 
2012.  The height of the frustum was determined using triangular geometry.  The outlet and inlet 
cylinders had a diameter of 6mm.  Both the inlet and outlet were 2mm in height. 
 
Figure 4.1:  Design 1 axial-flow bioreactor regions.  
(picture from COMSOL 4.3b simulation) 
Case 2.  Fluid naturally takes the path of least resistance, which would cause media in Case 1 to 
flow-through open regions as opposed to directly through the scaffold.  Also, the static bioreactor 
showed oxygen rich areas with limited use for hepatocytes due to diffusion limitations.  This 
suggested the possibility of truncating the bioreactor to the scaffold size without compromising 
nutrient distribution.  Additionally, a decrease in bioreactor volume would result in the use of less 




reduce bioreactor volume, area outside of the scaffold was eliminated from the design (Figure 
4.2).  The scaffold and bioreactor diameter were 14mm.  The semi-angle of the bioreactor was 
changed due to reduced bioreactor diameter and my intent to maintain the same height from the 
bioreactor exit.  Apart from 1 mm thick scaffolds, the possibility of using 2 mm thick scaffolds 
was tested as well.  
 
Figure 4.2:  Design 2 axial-flow bioreactor regions.  
(picture from COMSOL 4.3b simulation) 
Both Case 1 and Case 2 bioreactor geometries were generated in COMSOL Multiphysics, version 
4.3 (COMSOL, Inc., Burlington, MA), similar to previous publications [26].  In brief, three-
dimensional (3D) bioreactor models were generated using the work plane settings option in the 
Geometry tab; this allows 2D drawings to be extruded to create 3D bioreactor models.  Next, the 
sub-domain and boundary conditions are set in the Physics tab.  The cell seeding density used in 
flow-through simulation was identical to that discussed in chapter two.  The number of cells 
seeded in the 1mm and 2mm thick scaffolds for both Case 1 and Case 2 are seen in Table 4.1.  












Scaffold Thickness (mm) Scaffold Volume (mm
3
) Number of cells 
1 150 200,000 
2 310 400,000 
 
4.2.2.  Assumptions 
Assumptions used during flow simulation are listed below: 
 Physical properties (density and viscosity) of the growth medium used for 
culturing cells are equivalent to those of water at 37°C.   
 Effective diffusivity was constant, isotropic and is approximated using Mackie-
Meares relationship similar to that in the static bioreactor.   
 Porosity of the scaffold is constant either at 85% based on the chitosan-gelatin 
scaffolds to be used in the experiments) or 25% to assess the effect of reduced 
porosity 
 No flux at all exterior boundaries other than the inlet and outlet 
 Gravitation force was assumed to be negligible  
 Bioreactor operates at steady state 
 System is symmetric from the central axis 
 Deformation in the scaffold due to fluid flow is negligible. 
4.2.3.  Governing Equations  
Fluid behavior in non-porous regions was assumed to follow the Navier-Stokes equation, 




where P is the pressure, v is the velocity and η is the viscosity.  Convective mass transport 
through the porous region was assumed to follow the Brinkman equation,  
02
k
P        (4.2) 
where P is the pressure, η is the media viscosity, ν is the fluid velocity, and k is the permeability 
of the scaffold.  The permeability of the scaffold was calculated using the equation  
4
128
dnk A          (4.3) 
where d is the pore diameter and nA is the number of pores per unit area.  Based on the 
characterization of chitosan-gelatin scaffolds [24], a pore diameter of 55 µm and pore number of 
318 pores/mm
2
 were used.  The Brinkman equation was chosen because this equation takes into 
account the momentum transport by microscopic shear effects as well as pressure gradient forces 
involved in transport of the media from the free-flow region into the porous region.   
Using the steady state values obtained for velocities in three directions, the concentration profiles 
of oxygen and urea were obtained by solving the convective-diffusive equation,   
AAA rCuCD *)(*       (4.4) 
where D is the effective diffusivity, CA is the oxygen concentration at a given point, u is the fluid 
velocity and rA is the reaction rate.  Simulations were performed using the physics module 
Reacting Flow, Diluted Species, which was selected based on the module’s governing equations 
for mass transport.  The reaction rate was assumed to follow Michaelis-Menten kinetics for 
oxygen and zero order kinetics for urea production, as discussed in the static bioreactor 




flow bioreactors via proportioning based on the scaffold thickness.  Both oxygen and urea 
reactions were solved simultaneously, similar to static bioreactor simulation.   
Reynolds numbers were evaluated in order to assess the applicability of the Brinkman equation in 
the porous region.  Both the average and maximum Reynolds numbers were calculated for the 






        (4.5)  
where ρ is the fluid density, υi is the fluid interstitial velocity (average or maximum, depending 
on the Reynolds number of interest), and µ is the fluid viscosity, s is the sphericity 
(approximately 1 for short cylinders), εp is the porosity, and Dp is the pore diameter.   
The volumetric flow rate was varied for two reasons: i) to determine its effect on oxygen and urea 
concentration distributions and  ii) to obtain a flow rate that would provide a measurable inlet to 
outlet concentration difference necessary for experimental validation.  Volumetric flow rates 
tested, and each corresponding inlet velocity are shown in Table 4.2. 
Table 4.2:  Volumetric flow rate/inlet velocity equivalence. 








Meshing of all axial-flow bioreactor geometries were performed using a swept, mapped meshing, 




was made finer throughout the scaffold region to obtain more precise results in this area of 
interest.  The scaffold thickness was divided into 20 layers for 2mm thick scaffolds and 10 layers 
for 1mm thick scaffolds.  Additionally, scaffold diameter was divided into 30 sections.  The Case 
2 bioreactor, housing the 1mm thick scaffold contained a total of 91,890 nodes.  A grid test was 
performed to ensure that mesh quality did not affect profile results.  For grid test analysis, the 
maximum and minimum element sizes were changed to 0.25mm and 0.0025mm respectively, 
resulting in a total of 253,207 nodes throughout the case 2, 1mm thick scaffold bioreactor.  
Altering the node density changed the outlet oxygen concentration by 0.474%, which indicated 
that the mesh quality had been optimized at 91,890 nodes.   
Average outlet concentration was evaluated for the purpose of experimental validation and use in 
grid test evaluation.  The procedure for obtaining concentration profiles for axial-flow simulation 
is similar to that for static simulation.  An example of how to obtain average outlet concentration 
is in Appendix D.  
4.3.  RESULTS 
4.3.1.  Applicability of Brinkman Equation to Predict Flow Through Porous Medium 
Our group has extensively used Brinkman equation to evaluate flow-through porous medium in a 
variety of bioreactors [19, 25-27].  Based on those concepts, Brinkman equation was used in this 
study.  To understand the utility of the Brinkman equation, the average and maximum interstitial 
velocities in the porous region were retrieved from simulation.  Then the average and maximum 
Reynolds numbers were calculated (Table 4.3) for the highest flow rate tested (10mL/min).  
Detailed Reynolds number calculations for different flow rates are given in Appendix E.  Both 





Table 4.3:  Average and maximum Reynolds numbers for Q = 10 mL/min. 
 
Case1 Case2 (1mm) Case 2 (2mm) 
Average Reynolds Number 0.0234 0.109 0.103 
Maximum Reynolds Number 0.0787 0.139 0.136 
 
Since Darcy’s equation is generally used to evaluate flow through porous medium for Reynolds 
numbers less than one, simulation was also performed using the Darcy equation.  Simulation 
using Darcy’s equation showed no variance in output pressure drop compared to the simulation 
using the Brinkman equation.  As previous studies pertaining to axial-flow bioreactors performed 
by my peers used the Brinkman equation to characterize fluid flow through porous regions, I used 
the Brinkman equation for comparison purposes.  
4.3.2.  Case 1: 1mm Thick Scaffold 
4.3.2.1.  Pressure Drop 
Upon validation of using the Brinkman equation, the pressure distribution across the porous 
region where cells are grown was analysed.  The average pressure drop across the bioreactor was 
calculated by calculating the difference between the inlet and outlet average pressure.  Derived 
values, average surface evaluations were performed at the inlet and outlet to obtain the average 
pressure at each location.  An example of how to obtain average values at a surface is shown in 
Appendix D.  The average pressure drop across the reactor for each flow rate is shown in Table 
4.4.  Since these were based on Brinkman equation, the average pressure drop across the reactor 
increased as the flow rate increased.  
Table 4.4:  Case 1 average pressure drop at 25% porosity. 
Volumetric Flow Rate (mL/min) 0.1 1 10 





4.3.2.2.  Shear Stress Distribution 
Flow rate directly dictates the sufficiency of nutrients necessary for cellular activity and local 
shear stresses experienced by cells.  Very low flow rate could lead to nutrient deficiency and 
limited cell survivability.  However, high flow rate leads to high shear stresses and the upper limit 
for the perfusion rate is set by the tolerance of cells to shear force induced by the flowing fluid.  
In particular, increasing the shear stress from a low range of 0.001 – 0.033 Pa to a higher range of 
0.5 – 2.1 Pa, has been shown to decrease urea production to half the level [30].  Shear stress 
profiles of the scaffold region were developed to understand the shear stresses experienced by the 
cells at different volumetric flow rates (Figure 4.3).  The maximum shear stress increased as the 
flow rate increased.  Maximum shear stress was exhibited at the top of the inlet cylinder.  
 
Figure 4.3:  Effect of flow rate on shear stress at 25% porosity. 
Shear stress profiles demonstrated that maximum shear stress was exerted near the top of the inlet 
cylinder.  This was most evident at the maximum flow rate simulated, 10mL/min.  Shear stress 




was then performed.  The shear stress profile shown in Figure 4.4 revealed that the case 1 
bioreactor exerted shear stress values near zero, particularly in the scaffold region, even at the 
highest flow rate and lowest porosity simulated.  
 
Figure 4.4:  Shear stress profile for the bottom side of the scaffold at 10 mL/min and 25% 
porosity. 
  
Maximum scaffold shear stress was also evaluated and determined using derived values, volume 
maximum evaluation.  A maximum scaffold shear stress of 0.00195 Pa was experienced by cells 
in simulation when a flow rate of 10mL/min was simulated.  Profiles showed that shear stress was 
uniformly distributed throughout the scaffold region of the case 1 bioreactor. 
4.3.2.3.  Oxygen Consumption Characteristics: 
Simulations were performed with a defined rate law for oxygen to understand the nutrient 




) was the same as that used in 
the static bioreactors.  Oxygen concentration profiles were examined at different flow rates to 
determine the effect of flow rate on oxygen concentration distribution.  Oxygen concentration 




oxygen concentration became more uniformly distributed.  The oxygen profiles showed that 
oxygen rich areas, similar to those seen in the static bioreactor simulations, still exist. 
 
Figure 4.5:  Effect of flow rate on oxygen concentration distribution at 25% porosity. 
Oxygen concentration profiles demonstrated that oxygen was uniformly distributed throughout 
the case 1 bioreactor at flow rates as low as 1mL/min.  
4.3.2.4.  Urea Production: 
Simulations for urea production were performed to determine the distribution of a metabolic 
product in the scaffold.  These results showed (Figure 4.6) that urea was uniformly distributed for 
each of the three flow rates.  The urea concentrations were significantly lower for all three flow 
rates in Case 1, relative to static bioreactors.  In any case, urea toxicity was not a concern for the 





Figure 4.6:  Effect of flow rate on urea concentration. 
4.3.3.  Case 2:  1mm thick scaffold 
4.3.3.1.  Pressure Drop 
The average pressure drop for the case 2 reactor was obtained similar to Case 1 (Table 4.5).  The 
average pressure drop increased compared to pressure drop at the same flow rate for Case 1.  This 
suggests that truncating the bioreactor diameter to fit the scaffold size forced the fluid to pass 
through the scaffold, increasing the pressure drop. 
Table 4.5:  Average pressure drop with 1mm thick scaffold and 25% porosity. 
Volumetric Flow Rate (mL/min) 0.1 1 10 





4.3.3.2.  Shear Stress 
Shear stress profiles shown in Figure 4.7, demonstrated that the case 2, 1mm thick scaffold 
bioreactor exerted shear stress values near zero, particularly in the scaffold region.  The 
maximum shear stress in the scaffold region was 0.03162 Pa, at a volumetric flow rate of 
10mL/min.   
 
Figure 4.7:  Effect of flow rate on shear stress in 1mm thick scaffold at 25% porosity. 
4.3.3.3.  Oxygen Consumption Characterization 
Figure 4.8 shows the oxygen concentration profiles for three different flow rates over the range 
discussed.  Truncation of the bioreactor showed uniform distribution of oxygen throughout the 





Figure 4.8:  Effect of flow rate on oxygen concentration in 1mm thick scaffold at 25% 
porosity. 
  
4.3.3.4.  Urea Production 
Simulations for urea production similar to those discussed for case 1 were performed.  These 
results showed (Figure 4.9) that urea was uniformly distributed for each of the three flow rates.   
The urea concentrations were again significantly lower for all three flow rates, relative to static 
bioreactors.  Low urea concentrations discovered in both the case 1 and case 2 simulations led to 





Figure 4.9:  Effect of flow rate on urea concentration distribution at 25% porosity. 
4.3.4.  Case 2:  2mm Thick Scaffold 
4.3.4.1.  Pressure Drop 
Similar to other cases, average pressure drop values were obtained.  These results showed (Table 
4.6) an increase in pressure drop compared to Case 1 as well as Case 2 1mm thick scaffolds.  
Increased thickness proportionally increased the pressure drop across the scaffold. 
Table 4.6:  Average pressure drop with 2mm thick scaffold and 25% porosity. 
Volumetric Flow Rate (mL/min) 0.1 1 10 
Average Pressure Drop (Pa) 0.20 2.02 19.85 
 
The shown values for all three conditions were evaluated at 25% porosity which is used in 




the Brinkman equation, increased permeability at 85% is expected to provide significantly less 
pressure drop across the bioreactor.   
4.3.4.2.  Shear Stress 
Shear stress profiles were evaluated for flow rates of 10, 1, and 0.1 mL/min (Figure 4.10).   A 
maximum shear stress of 0.3765 Pa was exerted in the scaffold region at the highest flow rate 
simulated.  Profiles again demonstrated that exerted shear stress in the scaffold region of the case 
2, 2mm thick scaffold were negligible. 
 




4.3.4.1  Oxygen Consumption Characterization 
Oxygen concentration profiles associated with three different flow rates over the range discussed 
are shown in Figure 4.11.  Oxygen concentration was uniformly distributed at all flow rates 





), increased thickness increased the number of cells.  Hence the 
consumption of oxygen proportionally increased relative to 1mm thick scaffolds.   
 
Figure 4.11:  Effect of flow rate on oxygen concentration in 2mm thick scaffold at 25% 
porosity. 
 
4.4.  SUMMARY 
Simulations were performed to determine the effects of bioreactor geometry and volumetric flow 




bioreactor to fit the exact scaffold diameter improved the uniformity of oxygen distributions 
when compared at the same volumetric flow rate. Urea toxicity was significantly decreased in all 
cases for axial-flow reactors, when compared with urea concentrations in the static reactor with 
the same scaffold thickness.  Shear stress was also investigated due to concern for environmental 
condition concerns for cells.  Shear stress increased as flow rate increased, but a level of shear 
stress at which cells would be damaged or die was not encountered in case 1 or case 2.  It was 
concluded that the case 2 bioreactors should be constructed for experimental validation of the 









Using various assumptions and governing equations, simulations were performed in CFD.  In 
order to understand the utility of the simulation, experimental validation of nutrient distribution 
and consumption is necessary.  A six-well plate, with the dimensions discussed in chapter 2, was 
used for static experimental studies.  For flow-through experiments, an axial-flow bioreactor 
prototype was constructed with the dimensions discussed in chapter 3.  Chitosan-gelatin 
scaffolds, prepared by freeze drying, were utilized in the experimentation due to extensive 
analyses previously performed on those scaffolds being available in the laboratory.  Using the 
bioreactor and the scaffold, experiments were performed at the lowest flow rate discussed in 
simulation studies to measure nutrient distribution using residence time distribution analyses.  
Hepatocarcinoma cells (HepG2- cell line) were cultured and oxygen and urea concentration 
measurements were analyzed to validate model nutrient consumption and toxin production.  
Oxygen measurements were only performed on the flow-through system, as pinpointing an exact 
location for oxygen measurement in the scaffold inside of the static bioreactor scaffold would be 
impossible.  Urea concentration measurements were obtained for both the static and flow-through 
systems, as urea was shown to be uniformly distributed in all cases.  In addition, to understand the 
nutrient distribution in the bioreactor residence time distribution analysis using step input 




5.1.  METHODS AND MATERIALS 
Chitosan (190-310kDa MW and 85% degree of deacetylation), Gelatin Type-A (Bloom 300) 
from porcine skin, and glacial acetic acid were obtained from Sigma Aldrich Chemical Co. (St. 
Louis, MO).  Chloroform and Ethanol (200 proof) were obtained from Aaper Alcohol and 
Chemical Company (Shelbyville, KY).  Urea assay kit was obtained from Sigma Aldrich 
Chemical Co. (St. Louis, MO). 
5.1.1.  Scaffold construction 
Scaffolds of 1mm and 2mm thickness were prepared using a 10cm diameter circular mold on a 
Teflon sheet, following the procedure previously described [15].  In brief, 2%-2% (wt/v) chitosan 
gelatin solution was prepared in 0.5M acetic acid and 25mL of solution were poured into the 
molds.  The solution was frozen at -80 °C overnight and then placed in a Virtis freeze dryer 
(Gardiner, NY) overnight.  Obtained dry scaffolds were submerged in absolute ethanol to wash 
the acetic acid.  Using a custom-made punch, 14mm diameter scaffolds were cut and used in all 
experiments.  All scaffolds were washed in a phosphate buffered saline solution with a pH of 7.4 
prior to experimentation. 
5.1.2.  Residence time distribution analysis 
Experiments were performed to calculate mean residence time for both the 1mm thick scaffold 
bioreactor, using an open-loop flow system, similar to a previous publication [19] with some 
modifications.  In brief, the axial-flow bioreactor was constructed in house to the specifications of 
the case 2 reactor as explained in simulation discussion in chapter 3.  This bioreactor had a split 
design, where the top part had a conical structure leading to the outlet, and the bottom part 
provided the location for placement of the scaffold above the inlet.  This bioreactor was 
connected to the flow loop designed to include two fluid reservoirs (Figure 5.1) pumped 
separately using two syringes placed in one syringe pump (74900 series, Cole-Parmer Instrument 




with tracer.  Tubes were attached to the end of each syringe and connected to a three-way 
stopcock (V1 and V3).  The stopcocks diverted fluid either to another three-way stopcock (V2) or 
to a waste container.  Stopcock V2 allowed either the tracer or deionized water to enter the tube 
leading to the bioreactor.  Samples were collected from a tube connected to the bioreactor outlet.   
Stopcocks V1 and V2 were initially set to divert tracer toward the bioreactor while stopcock V3 
was set to divert deionized water toward the waste container.  The syringe pump flow rate was set 
at 0.1mL/min.  The tube path leading from the tracer syringe was filled with fluid and stopped 
once it reached stopcock V2.  Stopcocks V3 and V2 were then set to divert deionized water to the 
bioreactor while stopcock V1 was set to divert tracer solution toward the waste container.  
Deionized water was run through the reactor until steady state was achieved.  The tracer was then 
introduced by setting stopcock V3 to divert deionized water toward the waste container and 
setting stopcocks V3 and V2 to divert tracer solution toward the bioreactor.  The experiment 
timer began once the tracer solution reached the bioreactor inlet.  Samples at 0.2mL were taken 
every 15 minutes until the absorbance of the sample matched that of the initial tracer 
concentration in the syringe. 
 




Concentrations of tracer were determined using a spectrophotometer (Spectramax Emax 
spectrometer, Molecular Devices, Sunnyvale, CA) at 490 nm.  The method discussed in Bhaskar, 
2012, was used to determine the mean residence time.  RTD data and calculations are in 
Appendix F. 
5.1.3.  Cell culture.   




) was obtained from 
ATCC (Manassas,VA) and maintained in Eagle’s Minimum Essential Medium (EMEM) 
following vendor’s protocol.  In brief, EMEM was supplemented with 10% fetal bovine serum 
(Invitrogen Corp.).  Cells were incubated at 37°C, 5% CO2/95% air, and fed with fresh medium 
every other day.  When cells were confluent, they were detached with 0.25% (w/v) Trypsin – 
0.53mM EDTA obtained from Invitrogen Corp. (Carlsbad, CA), neutralized with the growth 
medium.  Cells were centrifuged at 270g for 5  min and dispersed in growth medium.   
As necessary, these cells were used in the experiments by counting viable cells using Trypan blue 
dye exclusion assay.  An appropriate number of cells were seeded onto each sterile 1mm and 
2mm thick chitosan-gelatin scaffold, and incubated overnight for cellular attachment.   
5.1.4.  Oxygen consumption validation. 
Experimental setup was similar to the RTD analysis, with few changes to the mode of operation 
(Figure 5.2).  Initially, all components (tubing and bioreactor) were dry steam sterilized at 134 C 
for 45 min.  The oxygen probe housing, oxygen probe, and bioreactor stands were disinfected 
with a 70% ethanol solution.  The pressure transducer and syringes were obtained in sterile 
packaging.  All surfaces, including the water bath and syringe pump were wiped down with the 
70% ethanol solution.  The entire flow loop (tubing, syringe, pressure transducer, bioreactor, and 




The cell containing scaffold was placed inside of the bottom half of the bioreactor and saturated 
with media.  The bioreactor was assembled and placed in an incubator at 37 C overnight for cell 
attachment.  The bioreactor was connected to the flow-loop in a sterile environment along with 
the oxygen probe and pressure transducer.  Growth medium was loaded into a syringe and placed 
in the syringe pump.   The tubing connecting the syringe and the bioreactor was passed through a 
water bath maintained at 37 ⁰C.  Based on the simulation studies explained in Chapter 3, the 
syringe pump was set to a flow rate of 0.1mL/min using the tubing diameter.  A waste jar was set 
up to collect the growth medium exiting the bioreactor.   
Timing of the experiment began once the first drop of media reached the bioreactor inlet.  The 
experiment lasted 2 hours, similar to RTD analysis.  Small samples (~0.2 mL) were collected 
every 30 minutes.  Using the oxygen flow-through electrode (Microelectrodes, Inc., Bedford, 
NH), outlet oxygen concentration was monitored in real-time.  After reaching steady state (~2 h 
based on four times the space time), oxygen reading was recorded for comparison with the 
simulation.  Exiting medium collected during experimentation was used for urea analysis.    
 
Figure 5.2:  Oxygen consumption validation experimental setup. 
  
           
             
                    
           
       




5.1.5.  Urea production validation 
Urea concentration analysis was performed in both the static and axial-flow reactor settings.  
Axial-flow reactor samples were taken during the experiment described in the oxygen 
consumption validation section.  The static bioreactor setup used a six-well plate and the 1mm 
chitosan-gelatin scaffolds discussed previously.  A sterile six-well plate was opened under a 
sterile hood.  Scaffolds for experimentation were prepared as discussed previously and placed 
into the middle of the six-plate.  Mesh was used to hold the scaffolds in place and was sterilized 
using a 70% ethanol solution.  The wells were then filled with media according to the dimensions 
of the simulated static reactor discussed in chapter 2, and taking into account displacement due to 
scaffold presence.   
Static reactor experiments ran for 48h and 50h, due to uncertainties with the amount of time 
required for cell attachment.  Samples were collected from each well at the end of the allotted 
experimentation period.  A spectrophotometer was used to compare the absorbance of each 
sample to that of water and a diluted urea solution.  These absorbance values were then used to 
calculate the urea concentration for each sample.   
5.2.  RESULTS 
5.2.1.  Residence time distribution 
The non-ideal fluid distribution is characterized using the residence time distribution (RTD).  The 
RTD measures the amount of time different molecules present in the fluid spend within the 
reactor [9, 18].  In other words, RTD is a measure of dispersal of a molecule in a flowing medium 
owing to the combined action of a velocity profile and molecular diffusion.  To understand the 
distribution of nutrients, a C(t)/Co curve (Figure 5.3) was plotted from which mean residence 
time, tm, was calculated.  The methodology used for this calculation is in Appendix F.  The tm for 




gave the effective volume to be nearly 95% of the volume of the bioreactor.  This confirmed 
uniform distribution of nutrients, similar to CFD profiles shown in Chapter 3.   
 
Figure 5.3:  RTD concentration vs. time plot. 
  
5.2.2.  Oxygen concentration comparison 
Non-ideal fluid flow patterns lead to non-uniform distribution of nutrients present in the fluid.  
The RTD analysis is independent of the metabolic reactions and hence nutrient consumption is 
not integrated into CFD modeling.  To understand the implications of non-ideal fluid distribution 
on tissue regeneration, oxygen consumption characteristics were analyzed.  The oxygen 
concentration collected by the oxygen probe was compared to the average outlet concentration 






Figure 5.4:  Comparison of outlet oxygen concentration. 
5.2.3.  Urea concentration comparison 
In order to understand the implications of non-ideal fluid distribution on tissue regeneration, 
production characteristics of the toxin urea were analyzed.  The urea concentration obtained by 
absorbance analysis was compared to the average urea concentration obtained in simulation.  





Figure 5.5:  Comprison of urea concentration.  
The experimental outlet urea concentrations generally agreed with predicted concentrations in 
static bioreactors. However, the model under predicted the outlet concentration compared to the 
experimental results from the axial-flow bioreactors.  When accounting for cell number increase 
during the 12 h incubation, urea production in 2mm thick scaffolds increased to 4.6 M from 3.2 
M but was still significantly lower than experimental measurements. 
5.3  SUMMARY 
 
Experimentation was necessary for model validation.  An RTD analysis was performed in order 
to determine the length of time the experiment should be run.  Outlet oxygen concentration data 
was recorded during experimentation for comparison with simulation values.  The model was 
able to predict outlet oxygen concentration with less than a ten percent difference.  The model 
was able to predict urea production concentrations in static bioreactors with much more accuracy 











6.1  CONCLUSIONS 
The axial-flow bioreactor developed showed improved nutrient distribution and possibility of 
culturing hepatocytes in 3D porous scaffolds.  The following are the conclusions based on the 
three objectives  
i)  To understand the limitations of the static bioreactor via CFD Simulation. 
As scaffold thickness increased, oxygen deficiency issues increased.  Placement of the scaffold 
on the bottom of the bioreactor inhibited diffusion of oxygen into cells along the bottom of the 
scaffold.  Decreased porosity led to oxygen deficiency issues in all scaffold thicknesses. Estrogen 
and urea concentration distributions posed no limitation on the static bioreactor setup.   
The static bioreactor was not capable of supporting three-dimensional hepatic cell cultures due to 




ii)  To develop an axial-flow bioreactor via CFD Simulation. 
The elimination of excess area outside of the scaffold region, despite being oxygen rich, did not 
inhibit nutrient distribution throughout the scaffold region.  Higher flow rates in the axial-flow 
bioreactor led to greater shear stresses inside of the scaffold region and larger pressure drops 
across the bioreactor.  Uniform oxygen concentration distributions were observed even at low 
flow rates as low as 0.1 mL/min.  Urea concentration was not a concern in these bioreactors.   
The truncated, case 2 axial-flow reactors experienced shear stresses that were nearly one-fourth 
that of the case 1 axial flow bioreactor.  The case 2 axial-flow bioreactor simulations 
demonstrated that nutrient distribution was more uniform when compared to the case 1 reactor at 
the same flow rate.  It was concluded from simulation that the case 2 bioreactor was the optimal 
environment for experimental validation. 
iii):  To validate the axial-flow bioreactor simulation with experimental results  
Obtained mean residence time (tm) was compared with the theoretical space time calculated from 
the volumetric flow rate and the volume of the bioreactor.  These calculations showed distribution 
of nutrients in the entire region with less than 5% dead space.  These regions are similar to those 
observed in the simulation results.  The model was able to closely predict outlet oxygen 
concentration  
6.2  RECOMENDATIONS 
1.  Need for appropriate kinetic parameters.  Kinetic constants obtained from 2D monolayer 
culture systems reported in literature were utilized in the simulation of cells on 3D porous 
scaffolds.  However, many in vitro experiments show that cells respond differently in attachment, 
morphology, migration, and proliferation on 3D scaffolds unlike traditional 2D-tissue culture.  
Hence, it is expected that kinetic parameters could change based on the culture condition.  Using 




model predications.  Hence performing experiments to determine the kinetic constants via 
experimentation is necessary.  An experiment using the bioreactors constructed for this study or 
ones of similar geometry should be used to perform the experiment.  The experiment should be 
conducted at four or more different flow rates.   
2.  Testing effect of drugs in the bioreactor.  In this study, I used three components to test the 
simulation:  oxygen, urea and estrogen.  One has to extend these to testing drugs and assess the 
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APPENDIX  A.  –Calculations for Kinetic Constants of Oxygen 
 
1. Initial concentration 
Using Henry’s Law @ 37° C 
HO2 and PO2 were obtained from Principles of Biomedical Engineering – Madihally 2010 
 
For 1 liter of water at 37° C = 991.27 g 
 





2. Km Value 
Use a cell density ratio to calculate Km in mol/m
3  





3. Vm Value 
Use a cell density ratio to calculate Km in mol/m
3  
Literature values from Devarapalli 2009 [6].  
 




4. Free Diffusivity at 37 °C 





5. Effective Diffusivity 
Use the Mackie-Meares relation to determine the effective diffusivity through the 
scaffold 
 
A. 85%  porosity -  φ = .85 
 






















APPENDIX  B.  – Calculations for Kinetic Constants of Estrogen 
 
1. Initial concentration of Estrogen. 




2. Km Value  
Km = 0.006E -3 mol/Liter was obtained from [8] 
 
3. Vm Value 
Vm = 0.32E -9 mol/mg protein/minute was obtained from [8].  Because of the units a 
value as to the amount of protein preset number of cells was needed.  This value of 5.5E -
6 g protein/10
6









4. Free Diffusivity of Estrogen at 37 °C 
Free diffusivity of Estrogen in water was obtained from [33]. 
 
5. Effective Diffusivity of Urea at 37 °C 
Use the Mackie-Meares relation to determine the effective diffusivity through the 
scaffold 
 
A. 85%  porosity -  φ = .85 
 









APPENDIX  C.  – Calculations for Kinetic Constants of Urea 
 
1. Zero order rate law constant for urea production.   
 
 
A. 2mm scaffold – 400,000 cells 
 
B. 1mm scaffold – 200,000 cells 
 
C. 0.75mm scaffold – 150,000 cells 
 
D. 0.5mm scaffold – 100,000 cells 
 
E. 0.25mm scaffold – 50,000 cells 
 
 
2. Free Diffusivity of Urea at 37 °C 
Free diffusivity of urea in blood was obtained from [5]. 
 
3. Effective Diffusivity of Urea at 37 °C 








A. 85%  porosity -  φ = 0.85 
 







APPENDIX  D. – COMSOL Simulation Procedures 
 
D.1 Start Up 
 




2. Select the 3D spatial dimension and then click the blue arrow pointing to the right to go 






















3. Select the physics module that applies to your simulation.  For the static bioreactor 
Transport of a Diluted Species was used.  You can also rename your dependent variables 




physics module for a single simulation.  Once selections have been made, click on the 







4. Next select the type of study.  A time dependent study was chosen for the static 
bioreactor.  All physics do not have to be selected for this study.  A green check mark 
means they will be solved for in the study.  It is possible to have more than one study.  













D.2  Static Bioreactor Geometry 
 
Creating the Static Bioreactor Shell 
 
1. The screen that pops up after finishing the set up will have a model builder frame, 
geometry frame, and graphics frame.  In the geometry frame change the length unit 


























2. Locate the geometry tab in the model builder frame and expand it by clicking on the 
triangle to the left of it .Right click geometry and select “Work Plane.”  A work plane 
will appear in the graphics window and “Work Plane1” will appear under “Geometry1” 








 The work plane can be renamed by right clicking on the work plane tab and selecting 
rename. In this simulation “Work Plane 1” will be renamed “Shell” because it will 
become the outside shell of the bioreactor.  Notice that the height of the work plane can 
be set in the work plane window under the z-coordinate section.  Leave the z-coordinate 















3. Right click on the “Plane Geometry” tab and select circle.  The bioreactor shell is hollow 
cylinder.  The radius of the circle should be changed to 16.5mm. Then click “Build All” 



























4. In order to give the bioreactor shell height use the extrude function.  Right click on “Shell 
(work plane1)” and select extrude.  Under “Distances from Plane” input 2.34mm as this 








5. The outside shell of the static bioreactor is now complete. 
 
 
Creating the Scaffold Region  
1. A new work plane is needed to create the scaffold region inside of the bioreactor.  Once 
again, right click on “Geometry1” and select Work Plane.  This work plane was renamed 
“Scaffold.”  In this simulation scaffold height was 0.5mm from the bottom of the 




























2. The scaffold is also a cylinder, so begin with a circle.  Under the “Scaffold” tab, right 






























3. The height of the scaffold varied in this study.  This example will be done with a 1mm 
thick scaffold.  Right click on “Scaffold” and select extrude.  Change the “Distances from 








4. The scaffold region is now complete.  The graphics section will show the static bioreactor 
with the scaffold inside. 
 
 





1. All constants and initial conditions can be input as parameters.  Expand the “Global 






2. Enter a name for the constant or initial value in the name box. 
 
3. Enter a value and units for the constant or initial value in the expression box 
 
 




5. Find the section that the constant or initial value should be input into.  For example, the 
effective diffusivity of oxygen, DeffO2, will be input into a diffusion section for 
Transport of a Diluted Species (Oxygen).  Notice that the domain must be selected so that 








6. This is also done in the initial values section with the initial concentration of a species.   
7. The second diffusion section is for the free diffusivity of a species in the non-porous 
region. 
 
*Note, to add a diffusion, reactions, initial values, flux, etc. section, right click on the 
Transport of a Diluted Species (Oxygen) tab and select the section needed. 
 
 
D.4  Equations Input 
 
1. Equations for the concentration change can either be put into the reactions section 
directly or input into the variables section. 
 
2. To input the equation into the variables section, expand the “Model” tab, then expand the 








3. Write the equation name in the name box 
 
4. Input the expression to be calculated at each node.  Notice that parameters and variables 
can be input into equations 
 
 


































D.5  Profiles and Derived Values 
 
1. Profiles for shear rate, concentration, velocity and a variety of other variables can be 
obtained once the simulation has been run. 
   






3. Right click on the “Results” tab to select the type of plot you want.  For this example we 







4. A new 3D plot section will appear 
 
5. Right click on the new plot and you can rename the section so that profile identification is 






6. Again right click and choose the type of profile you want to see.  For this example we 








7. A new section will appear under the Oxygen Concentration section 
 
8. Here you can choose the expression you want to plot by clicking on the green and orange 























































10. The number of slices or coordinates of a slice can be selected in the Plane Data section, 





11. Volume and Surface averages/maximums can be obtained from the Derived Values 



































13. A box will new section will appear that allows you to select the volume(s) for which you 
want to find the average.  We will find the average volume concentration of oxygen 




14. Notice that both domains are chosen so that the entire volume is included 
 
15. Oxygen concentration has been selected for the expression, similarly to how we choose it 
for the concentration profile. 
 
 










Volumetric Flow Rate 
(mL/min) 10 5 1 
Volume Average Velocity 2.20E-04 6.882E-05 9.79E-06 
Volume Maximum Velocity 7.42E-04 1.48E-04 2.25E-05 
Average Reynolds Number 0.02338 0.00730 0.00104 









Case 2 (2mm) 
Volumetric Flow Rate (mL/min) 10 5 0.1 
Volume Average Velocity 9.72E-04 1.00E-04 1.00E-05 
Volume Maximum Velocity 0.00128 1.10E-04 1.50E-05 
Average Reynolds Number 0.10307 0.01064 0.00106 




Case 2 (1mm) 
Volumetric Flow Rate (mL/min) 10 5 1 0.1 
Volume Average Velocity 0.00103 5.13E-04 1.00E-04 1.00E-05 
Volume Maximum Velocity 0.00131 6.55E-04 1.14E-04 1.30E-05 
Average Reynolds Number 0.10923 0.05444 0.01064 0.00106 









Eliminating negative values from (a-aw-ac)/(a0-aw-ac) gives the values to be plotted and new 
time values 
Time(s) Time(min) c/c0 
      
0 0 0 
240 4 0.04299497 
480 8 0.16254195 
720 12 0.35067114 
960 16 0.22797819 
1200 20 0.40415268 
1440 24 0.55201342 
1680 28 0.54005872 
1920 32 0.59102349 
2160 36 0.47776846 
2400 40 0.45574664 
3000 50 0.6482802 
3600 60 0.71875 
 
Chapman 3 parameter fit data obtained from Sigma Plot 
Parameter Value StdErr CV(%) Dependencies 
a 6.94E-01 
1.17E-





Time(s) a a0 a-aw-ac a0-aw-ac (a-aw-ac)/(a0-aw-ac) c/co new Time(s)
0 0 0.039 1.661 -0.032666667 1.58933333 -0.020553691 0
4 240 0.055 1.661 -0.016666667 1.58933333 -0.010486577 0 0 0
8 480 0.14 1.661 0.068333333 1.58933333 0.042994966 0.042994966 240 0.042995
12 720 0.33 1.661 0.258333333 1.58933333 0.162541946 0.162541946 480 0.162542
16 960 0.629 1.661 0.557333333 1.58933333 0.350671141 0.350671141 720 0.350671
20 1200 0.434 1.661 0.362333333 1.58933333 0.227978188 0.227978188 960 0.227978
24 1440 0.714 1.661 0.642333333 1.58933333 0.404152685 0.404152685 1200 0.404153
28 1680 0.949 1.661 0.877333333 1.58933333 0.552013423 0.552013423 1440 0.552013
32 1920 0.93 1.661 0.858333333 1.58933333 0.540058725 0.540058725 1680 0.540059
36 2160 1.011 1.661 0.939333333 1.58933333 0.59102349 0.59102349 1920 0.591023
40 2400 0.831 1.661 0.759333333 1.58933333 0.477768456 0.477768456 2160 0.477768
50 3000 0.796 1.661 0.724333333 1.58933333 0.455746644 0.455746644 2400 0.455747
60 3600 1.102 1.661 1.030333333 1.58933333 0.648280201 0.648280201 3000 0.64828










01 5.31E+01 0.937929 
 
      0.694*(1-Exp(-0.0532*x))^1.3 
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